Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
Research ArticleClinical Review

Role of nutrition in preventing cancer

Richard Béliveau and Denis Gingras
Canadian Family Physician November 2007, 53 (11) 1905-1911;
Richard Béliveau
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: beliveau.richard@uqam.ca
Denis Gingras
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

In their landmark study, Doll and Peto showed that 75% to 80% of all cancers diagnosed in the United States in 1970 might have been prevented by altering lifestyle factors, such as smoking and diet.1 Subsequently, their conclusions were confirmed by a large number of studies. Researchers currently estimate that diet could account for approximately 30% of cancer deaths, similar to the number accounted for by smoking.2

The close relationship between diet and cancer is suggested by the large variation in rates of specific cancers in different countries and by the spectacular changes observed in the incidence of cancer in migrating populations.1–3 For example, studies have shown that Asians have a 25-fold lower incidence of prostate cancer and a 10-fold lower incidence of breast cancer than inhabitants of Western countries do, but that rates of these cancers dramatically increase following migration to the West.2 The importance of lifestyle factors in the development of cancer was also shown in studies of mono-zygotic twins (who share all genes). Inherited genetic factors were shown to be responsible for only about 15% of all cancer cases.4 These observations indicate that most cancers are not of hereditary origin and that lifestyle factors, such as dietary habits, have a profound influence on their development.

Quality of evidence

Relevant papers were identified by searching PubMed from January 1980 to December 2006 using the key words cancer, diet, prevention, angiogenesis, inflammation, and phytochemicals. Articles on the chemopreventive potential of specific foods or food groups were sought using the key words for these groups (eg, cruciferous, allium, soy, citrus, tomato, turmeric, berries, and green tea) or the key words for the anticancer molecules found in these foods (eg, isothiocyanates, sulforaphane, sulfides, resveratrol, curcumin, and epigallocatechin-3-gallate). Evidence of the chemopreventive effects of various components of food comes from several hundred case-control and prospective epidemiologic studies, and this relationship is strengthened by a large body of evidence derived from animal and laboratory studies.

Many epidemiologic studies have consistently linked abundant consumption of foods of plant origin, such as fruit, vegetables, whole grains, legumes, nuts, seeds, and tea, with decreased risk of developing various of cancers.2,5 When results of studies on all types of cancer are taken together, as many as 80% show a substantial decrease in risk with higher intake of at least 1 vegetable or fruit category examined2 (Table 12). This is particularly true for cancers of the upper gastrointestinal tract (Table 22); for example, studies indicate that as many as 75% of colorectal cancers, the second leading cause of death due to cancer in Canada, could be prevented by increasing the amount of plant-based food in the diet.6

View this table:
  • View inline
  • View popup
Table 1

Summary of results of case-control and cohort studies of all types of cancer showing an inverse association between consumption of various categories of fruit and vegetables and risk of cancer: Overall level of evidence is I.

View this table:
  • View inline
  • View popup
Table 2

Levels of evidence for decreased risk of various types of cancer with consumption of fruit and vegetables

These observations suggest that food of vegetable origin is an essential source of molecules with chemopreventive properties. This hypothesis is strengthened by many experimental data obtained from studies using cellular and animal models in which molecules isolated from various food sources were found to interfere with development of several cancers.7,8

Interfering with the development of precancerous tumours

Carcinogenesis is generally a slow process during which precancerous cells must accumulate several mutations in the genes involved in growth control, resistance to apoptosis, and induction of angiogenesis in order to grow and invade the host tissues9 (Figure 110). This process, which might take place over several years (even several decades), offers a large therapeutic window for blocking the development of cancer. The low genetic diversity of precancerous cells and the absence of an appropriate blood supply render the cells much more vulnerable to anticancer molecules than mature tumour cells would be.

Figure 1
  • Download figure
  • Open in new tab
Figure 1 Steps in carcinogenesis: For many years, or even decades, cancerous cells remain very vulnerable; only a few will succeed in reaching the malignant stage

This vulnerability makes it possible to intervene and interfere at several stages of tumour development and thus prevent onset of disease.

Preventing cancer by blocking development of these precancerous cells is extremely important because even healthy people have a certain number of latent tumours in their tissues. Studies of people who died from causes unrelated to cancer have shown that 30% to 50% of women aged 40 to 50 years had premalignant microscopic breast tumours, and 40% of similarly aged men had precancerous cells in the prostate.11 Even more striking, virtually every person (98%) had small latent tumours in the thyroid, although these tumours are only very rarely observed in the clinic (Table 311). It thus seems that the spontaneous formation of small tumours happens frequently over a lifetime, but that in most cases the growth of these small tumours is tightly controlled by our natural defence mechanisms, and they remain in a microscopic and harmless state.12 The appearance of clinically detectable cancer thus implies that precancerous cells have overwhelmed these defences and acquired the ability to grow and invade the host tissues.

View this table:
  • View inline
  • View popup
Table 3

Proportion of tumours detected at autopsy and clinically: Tumours had formed spontaneously.

Anticancer properties of plant-based food: the importance of phytochemicals

There is now considerable evidence that the chemopreventive properties of plant-based food are related to their ability to block the progression of latent microtumours. These properties arise from the high content of phytochemicals, molecules that target several key events in the development of cancer. Intensive research conducted over the last few years has shown that phytochemicals derived from the diet interfere with tumour progression by acting directly on tumour cells as well as by modifying the tumour’s microenvironment (stroma) and creating physiologic conditions that are hostile to tumour growth.

Direct inhibitory actions on tumour cells

Reduction of damage to DNA

Free radicals, environmental or diet-associated chemicals, and some metabolites all have the capacity to severely damage cell DNA, which might ultimately lead to cancer.13 Several chemopreventive phytochemicals elicit their anticancer effects by modulating the enzymatic systems responsible for neutralizing these carcinogens, either by reducing their carcinogenic potential or by increasing their excretion.14–16 For example, isothiocyanates, compounds found in abundance in cruciferous vegetables, inhibit tumourigenesis by reducing genetic damage induced by a wide variety of chemical carcinogens.17,18 Phytochemicals, which modulate the host’s defence mechanism against DNA-damaging molecules, are also found in several other types of fruit and vegetables, including members of the genus Allium (such as garlic)19 and citrus fruit.20 The ability of these molecules to reduce the oncogenic potential of carcinogens thus makes them an efficient first-line defence against cancer.16–19

Cytotoxicity against tumour cells

Several phytochemicals also inhibit tumour growth by directly inducing cancer cell death by apoptosis. For example, phenethyl isothiocyanate from cruciferous vegetables, curcumin from turmeric, and resveratrol from grapes have all been shown to possess strong pro-apoptotic activity against cells isolated from a variety of tumours.21–23 This activity correlates with inhibition of tumour growth in animals. Recent work has shown that some phytochemicals also sensitize tumour cells to apoptotic cues derived from natural pro-apoptotic stimuli, such as tumour necrosis factor–related apoptosis-inducing ligand.24,25 Overall, the cytotoxic properties of diet-derived phytochemicals contribute to the chemopreventive effects associated with intake of plant-derived foods and could play an essential role in preventing growth of cells that have already acquired an initiated phenotype (precancerous cells).

Effects on tumour microenvironment

Antiangiogenic properties

Angiogenesis is the process by which tumour cells stimulate formation of new blood vessel networks that sustain the development of cancer by providing oxygen and nutrients to tumour cells.26 Work from our laboratory has shown that several phytochemicals possess strong antiangiogenic activity and that this effect likely plays an important role in their chemopreventive properties.27,28 For example, epigallocatechin-3-gallate (EGCG), an abundant polyphenol found in green tea, potently inhibits vascular endothelial growth factor receptor-2, a key receptor involved in tumour angiogenesis.29 The inhibitory effect occurs with low concentrations of EGCG (concentrations achievable through diet), suggesting that this antiangiogenic effect is relevant in vivo.28 Accordingly, oral infusion of a polyphenolic fraction isolated from green tea at a human achievable dose (equivalent to 6 cups of green tea per day) strongly inhibits development of prostate cancer and increases the survival of transgenic mice that spontaneously develop this cancer.30 Interestingly, moderate consumption of green tea by humans was also recently associated with clear clinical benefits for some patients with chronic lymphocytic leukemia.31

In a similar manner, ellagic acid,32 a phenolic acid found in high quantities in some fruit, such as raspberries and strawberries, and delphinidin,33 an anthocyanidin abundant in blueberries, also block vascular endothelial growth factor receptor-2 activity and also strongly inhibit the activity of another receptor found in perivascular cells, platelet-derived growth factor receptor.32,33 This combined inhibitory effect of 2 receptor tyrosine kinases that are both essential for angiogenesis leads to inhibition of this process in both in vitro and in vivo assays29,33 in a manner similar to the synergistic anticancer effects observed with pharmacologic inhibition of these receptors.34 There is growing evidence that the antiangiogenic effects of these phytochemicals play a crucial role in their chemopreventive activity by preventing latent tumours from acquiring the blood vessel network necessary to sustain their growth and permit them to invade host tissues.

Anti-inflammatory effects

It is becoming increasingly clear that inflammatory stimuli participate in the progression of several cancers, including those of the colorectum, breast, and lung.35 The close relationship between inflammation and cancer is suggested by the identification of a number of inflammatory conditions that predispose patients to cancer (Table 436) as well as by the chemopreventive effects that anti-inflammatory cyclooxygenase-2 (COX-2) inhibitors, such as celecoxib, have on risk of colorectal cancer.37 Although the severe cardiovascular side effects associated with these drugs preclude their use as prophylactic agents,38 these effects nevertheless indicate that reducing inflammation represents a promising approach to preventing cancer.

View this table:
  • View inline
  • View popup
Table 4

Some inflammatory conditions that predispose patients to cancer

There is now considerable evidence that Western diets rich in refined starches, sugar, and saturated and trans fatty acids and poor in fruit, vegetables, fibre, ω-3 fatty acids, and whole grains promote inflammation.39 Inflammatory and immune cells from those consuming typical Western diets contain a high proportion of the pro-inflammatory ω-6 polyunsaturated fatty acid (PUFA) arachidonic acid and a low proportion of anti-inflammatory ω-3 PUFAs eicosapentenoic acid and docosahexenoic acid.40 As arachidonic acid is the precursor of 2-series prostaglandins and 4-series leukotrienes, which are highly active mediators of inflammation, a high dietary ω-6–to–ω-3 ratio results in generation of a pro-inflammatory state that could sustain the onset of several diseases, including cardiovascular disease, diabetes, and certain types of cancer.39,41

In addition to the important role of dietary PUFAs, there is also growing evidence that several phytochemicals from dietary sources reduce inflammatory processes, and that this anti-inflammatory effect contributes to their anticancer properties.42 For example, curcumin (the yellow pigment of turmeric), the green tea polyphenol EGCG, and resveratrol from grapes have all been shown to markedly reduce the expression of COX-2, an effect related to blockading the activity of the nuclear factor-κB transcription factor.7,42,43 This effect is likely to occur in humans, as reflected by the decrease in serum levels of the inflammatory prostaglandin PGE2 following oral administration of curcumin.44

Conclusion

A large number of epidemiologic, animal, and laboratory studies indicate that abundant consumption of food of plant origin reduces the risk of several types of cancer. The chemopreventive effect is related to the high content in these foods of phytochemicals with potent anticancer and anti-inflammatory properties. These properties block precancerous cells from developing into malignant cells by interfering directly with tumour cells and by preventing generation of an inflammatory microenvironment that would sustain the progression of the tumours. In many cases, these anticancer phytochemicals interfere with tumour promotion and progression by mechanisms identical to those through which synthetic molecularly targeted chemotherapeutic agents exert their activity (Table 5).7,42,45

View this table:
  • View inline
  • View popup
Table 5

Pharmacologic targets of diet-derived phytochemicals

Unlike synthetic molecules, however, whose inherent toxicity limits their use for prevention (eg, COX-2 inhibitors), the anticancer molecules present naturally in food are selected by evolution to be beneficial for health and, therefore, do not have secondary harmful effects. Daily intake of food rich in anticancer molecules could thus be compared to a preventive, non-toxic version of chemotherapy that is harmless to the physiology of normal tissue and stops microtumours from attaining a stage that would allow them to have pathologic consequences. Based on these considerations, there is no doubt that all patients, particularly those who have family history of cancer, should be strongly encouraged to change their dietary habits to include at least 5 to 10 servings daily of plant-based food, especially food with the highest content of anticancer phytochemicals (Figure 210). Such a change, coupled with a reduction in consumption of red meat (which is associated with an increased risk of colorectal46 and some types of breast47 cancer), maintenance of physical activity and appropriate body mass, and not smoking could substantially reduce the burden of cancer in Canada.

Figure 2
  • Download figure
  • Open in new tab
Figure 2

Including foods with chemopreventive properties in a daily diet

Levels of evidence

Level I: At least one properly conducted randomized controlled trial, systematic review, or meta-analysis

Level II: Other comparison trials, non-randomized, cohort, case-control, or epidemiologic studies, and preferably more than one study

Level III: Expert opinion or consensus statements

Acknowledgement

This work was supported by grants from the Fondation Charles-Bruneau and the Cancer Research Society of Canada Inc. Dr Béliveau holds the Chaire en prévention et en traitement du cancer at the University of Quebec at Montreal and the Chaire Claude-Bertrand en neurochirurgie at the University of Montreal.

Notes

EDITOR’S KEY POINTS

  • Even healthy people can have microtumours in their tissues. It appears that the growth of these small tumours is tightly controlled by our natural defence mechanisms, but these defences can be overwhelmed.

  • Case-control, epidemiologic, and laboratory studies have shown that certain foods of plant origin have chemoprotective properties related to their ability to block the progression of latent microtumours into mature tumours.

  • Canada’s Food Guide recommends intake of 7 to 10 servings of fruit and vegetables daily for adults, depending on age and sex. It might be prudent to choose foods that have high levels of anticancer phytochemicals.

POINTS DE RÉPÈRE DU RÉDACTEUR

  • Même une personne en santé peut héberger des microtumeurs dans ses tissus. On croit que la croissance de ces petites tumeurs est étroitement contrôlée par les mécanismes de défense naturels, mais ces défenses peuvent être débordées.

  • Des études épidémiologiques, de cas-témoins et en laboratoire ont montré que certains aliments d’origine végétale possèdent des propriétés chimioprotectrices reliées à leur capacité de bloquer la transformation des microtumeurs latentes en tumeurs matures.

  • Le Guide alimentaire canadien recommande pour les adultes un apport quotidien de 7 à 10 portions de fruits et légumes, selon l’âge et le sexe. Il semblerait judicieux de choisir les aliments possédant un niveau élevé de phytochimiques anticancéreux.

Footnotes

  • This article has been peer reviewed.

  • Competing interests

    None declared

  • Copyright© the College of Family Physicians of Canada

References

  1. ↵
    1. Doll R,
    2. Peto R
    . The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981;66:1191-308.
    OpenUrlPubMed
  2. ↵
    American Institute for Cancer Research, World Cancer Research Fund. Food, nutrition, and the prevention of cancer: a global perspective. Washington, DC: American Institute for Cancer Research; 1997.
  3. ↵
    1. Willett WC
    . Diet and cancer. Oncologist 2002;5:393-404.
    OpenUrl
  4. ↵
    1. Lichtenstein P,
    2. Holm NV,
    3. Verkasalo PK,
    4. Iliadou A,
    5. Kaprio J,
    6. Koskenvuo M,
    7. et al
    . Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000;343:78-85.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Gescher A,
    2. Pastorino U,
    3. Plummer SM,
    4. Manson MM
    . Suppression of tumour development by substances derived from the diet—mechanisms and clinical implications. Br J Clin Pharmacol 1998;45:1-12.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Thomson CA,
    2. LeWinn K,
    3. Newton TR,
    4. Alberts DS,
    5. Martinez ME
    . Nutrition and diet in the development of gastrointestinal cancer. Curr Oncol Rep 2003;5:192-202.
    OpenUrlPubMed
  7. ↵
    1. Surh YJ
    . Cancer chemoprevention with dietary phytochemicals. Nature Rev Cancer 2003;3:768-80.
    OpenUrlCrossRefPubMed
  8. ↵
    1. Dorai T,
    2. Aggarwal BB
    . Role of chemopreventive agents in cancer therapy. Cancer Lett 2004;215:129-40.
    OpenUrlCrossRefPubMed
  9. ↵
    1. Hanahan D,
    2. Weinberg RA
    . The hallmarks of cancer. Cell 2000;100:57-70.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Béliveau R,
    2. Gingras D
    . Foods that fight cancer: preventing cancer through diet. Toronto, ON: McClelland & Stewart Ltd; 2006.
  11. ↵
    1. Black WC,
    2. Welch HG
    . Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med 1993;328:1237-43.
    OpenUrlCrossRefPubMed
  12. ↵
    1. Folkman J,
    2. Kalluri R
    . Cancer without disease [abstract]. Nature 2004;427:787.
    OpenUrlCrossRefPubMed
  13. ↵
    1. Ames BN,
    2. Gold LS,
    3. Willett WC
    . The causes and prevention of cancer. Proc Natl Acad Sci USA 1995;92:5258-65.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Ioannides C,
    2. Lewis DF
    . Cytochromes P450 in the bioactivation of chemicals. Curr Top Med Chem 2004;4(16):1767-88.
    OpenUrlCrossRefPubMed
    1. Conney AH
    . Enzyme induction and dietary chemicals as approaches to cancer chemoprevention: the seventh DeWitt S. Goodman lecture. Cancer Res 2003;63:7005-31.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Talalay P
    . Chemoprotection against cancer by induction of phase 2 enzymes. Biofactors 2000;12:5-11.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Hecht SS
    . Chemoprevention of cancer by isothiocyanates, modifiers of carcinogen metabolism. J Nutr 1999;129:768S-74S.
    OpenUrlPubMed
  17. ↵
    1. Talalay P,
    2. Fahey JW
    . Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism. J Nutr 2001;131:3027S-33S.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Guyonnet D,
    2. Belloir C,
    3. Suschetet M,
    4. Siess MH,
    5. Le Bon AM
    . Mechanisms of protection against aflatoxin B(1) genotoxicity in rats treated by organosulfur compounds from garlic. Carcinogenesis 2002;23:1335-41.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. Hahn-Obercyger M,
    2. Stark AH,
    3. Madar Z
    . Grapefruit and oroblanco enhance hepatic detoxification enzymes in rats: possible role in protection against chemical carcinogenesis. J Agric Food Chem 2005;53:1828-32.
    OpenUrlPubMed
  20. ↵
    1. Thornalley PJ
    . Isothiocyanates: mechanism of cancer chemopreventive action. Anticancer Drugs 2002;13:331-8.
    OpenUrlCrossRefPubMed
    1. Karunagaran D,
    2. Rashmi R,
    3. Kumar TR
    . Induction of apoptosis by curcumin and its implications for cancer therapy. Curr Cancer Drug Targets 2005;5:117-29.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Jang M,
    2. Cai L,
    3. Udeani GO,
    4. Slowing KV,
    5. Thomas CF,
    6. Beecher CW,
    7. et al
    . Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997;275:218-20.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    1. Jeon KI,
    2. Rih JK,
    3. Kim HJ,
    4. Lee YJ,
    5. Cho CH,
    6. Goldberg ID,
    7. et al
    . Pretreatment of indole-3-carbinol augments TRAIL-induced apoptosis in a prostate cancer cell line, LNCaP. FEBS Lett 2003;544:246-51.
    OpenUrlCrossRefPubMed
  23. ↵
    1. Jung EM,
    2. Park JW,
    3. Choi KS,
    4. Park JW,
    5. Lee HI,
    6. Lee KS,
    7. et al
    . Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis through CHOP-independent DR5 upregulation. Carcinogenesis 2006;27:2008-17.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. Folkman J
    . Angiogenesis. Annu Rev Med 2006;57:1-18.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Tosetti F,
    2. Ferrari N,
    3. De Flora S,
    4. Albini A
    . “Angioprevention”: angiogenesis is a common and key target for cancer chemopreventive agents”. FASEB J 2002;16(1):2-14.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Béliveau R,
    2. Gingras D
    . Green tea: prevention and treatment of cancer by nutraceuticals. Lancet 2004;364:1021-2.
    OpenUrlCrossRefPubMed
  27. ↵
    1. Lamy S,
    2. Gingras D,
    3. Béliveau R
    . Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation. Cancer Res 2002;62:381-5.
    OpenUrlAbstract/FREE Full Text
  28. ↵
    1. Gupta S,
    2. Hastak K,
    3. Ahmad N,
    4. Lewin JS,
    5. Mukhtar H
    . Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc Natl Acad Sci USA 2001;98:10350-5.
    OpenUrlAbstract/FREE Full Text
  29. ↵
    1. Shanafelt TD,
    2. Lee YK,
    3. Call TG,
    4. Nowakowski GS,
    5. Dingli D,
    6. Zent CS,
    7. et al
    . Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies. Leuk Res 2006;30:707-12.
    OpenUrlCrossRefPubMed
  30. ↵
    1. Labrecque L,
    2. Lamy S,
    3. Chapus A,
    4. Mihoubi S,
    5. Durocher Y,
    6. Cass B,
    7. et al
    . Combined inhibition of PDGF and VEGF receptors by ellagic acid, a dietary-derived phenolic compound. Carcinogenesis 2005;26:821-6.
    OpenUrlAbstract/FREE Full Text
  31. ↵
    1. Lamy S,
    2. Blanchette M,
    3. Michaud-Levesque J,
    4. Lafleur R,
    5. Durocher Y,
    6. Moghrabi A,
    7. et al
    . Delphinidin, a dietary anthocyanidin, inhibits vascular endothelial growth factor receptor-2 phosphorylation. Carcinogenesis 2006;27:989-96.
    OpenUrlAbstract/FREE Full Text
  32. ↵
    1. Bergers G,
    2. Song S,
    3. Meyer-Morse N,
    4. Bergsland E,
    5. Hanahan D
    . Benefits of targeting both pericytes and endothelial cells in the tumour vasculature with kinase inhibitors. J Clin Invest 2003;111:1287-95.
    OpenUrlCrossRefPubMed
  33. ↵
    1. Coussens LM,
    2. Werb Z
    . Inflammation and cancer. Nature 2002;420:860-7.
    OpenUrlCrossRefPubMed
  34. ↵
    1. Balkwill F,
    2. Charles KA,
    3. Mantovani A
    . Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005;7:211-7.
    OpenUrlCrossRefPubMed
  35. ↵
    1. Steinbach G,
    2. Lynch PM,
    3. Phillips RK,
    4. Wallace MH,
    5. Hawk E,
    6. Gordon GB,
    7. et al
    . The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000;342:1946-52.
    OpenUrlCrossRefPubMed
  36. ↵
    1. Bertagnolli MM,
    2. Eagle CJ,
    3. Zauber AG,
    4. Redston N,
    5. Soloman SD,
    6. Kim K,
    7. et al
    . Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 2006;355:873-84.
    OpenUrlCrossRefPubMed
  37. ↵
    1. Giugliano D,
    2. Ceriello A,
    3. Esposito K
    . The effects of diet on inflammation: emphasis on the metabolic syndrome. J Am Coll Cardiol 2006;48:677-85.
    OpenUrlCrossRefPubMed
  38. ↵
    1. Calder PC
    . Dietary modification of inflammation with lipids. Proc Nutr Soc 2002;61:345-58.
    OpenUrlCrossRefPubMed
  39. ↵
    1. Larsson SC,
    2. Kumlin M,
    3. Ingelman-Sundberg M,
    4. Wolk A
    . Dietary long-chain n-3 fatty acids for the prevention of cancer: a review of potential mechanisms. Am J Clin Nutr 2004;79:935-45.
    OpenUrlAbstract/FREE Full Text
  40. ↵
    1. Surh YJ,
    2. Chun KS,
    3. Cha HH,
    4. Han SS,
    5. Keum YS,
    6. Park KK,
    7. et al
    . Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat Res 2001;480–1:243-68.
    OpenUrl
  41. ↵
    1. Aggarwal BB,
    2. Shishodia S
    . Suppression of the nuclear factor-kappaB activation pathway by spice-derived phytochemicals: reasoning for seasoning. Ann NY Acad Sci 2004;1030:434-41.
    OpenUrlCrossRefPubMed
  42. ↵
    1. Sharma RA,
    2. Euden SA,
    3. Platton SL,
    4. Cooke DN,
    5. Shafayat A,
    6. Hewitt HR,
    7. et al
    . Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 2004;10:6847-54.
    OpenUrlAbstract/FREE Full Text
  43. ↵
    1. D’Incalci M,
    2. Steward WP,
    3. Gescher AJ
    . Use of cancer chemopreventive phytochemicals as antineoplastic agents. Lancet Oncol 2005;6:899-904.
    OpenUrlCrossRefPubMed
  44. ↵
    1. Chao A,
    2. Thun MJ,
    3. Connell CJ,
    4. McCullough ML,
    5. Jacobs EJ,
    6. Flanders WD,
    7. et al
    . Meat consumption and risk of colorectal cancer. JAMA 2005;293:172-82.
    OpenUrlCrossRefPubMed
  45. ↵
    1. Cho E,
    2. Chen WY,
    3. Hunter DJ,
    4. Stampfer MJ,
    5. Colditz GA,
    6. Hankinson SE,
    7. et al
    . Red meat intake and risk of breast cancer among premenopausal women. Arch Intern Med 2006;166:253-9.
    OpenUrl
PreviousNext
Back to top

In this issue

Canadian Family Physician: 53 (11)
Canadian Family Physician
Vol. 53, Issue 11
1 Nov 2007
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Role of nutrition in preventing cancer
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Role of nutrition in preventing cancer
Richard Béliveau, Denis Gingras
Canadian Family Physician Nov 2007, 53 (11) 1905-1911;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Role of nutrition in preventing cancer
Richard Béliveau, Denis Gingras
Canadian Family Physician Nov 2007, 53 (11) 1905-1911;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Quality of evidence
    • Interfering with the development of precancerous tumours
    • Anticancer properties of plant-based food: the importance of phytochemicals
    • Conclusion
    • Levels of evidence
    • Acknowledgement
    • Notes
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • How Can Research on Plants Contribute to Promoting Human Health?
  • The Dietary Flavones Apigenin and Luteolin Impair Smooth Muscle Cell Migration and VEGF Expression through Inhibition of PDGFR-{beta} Phosphorylation
  • Google Scholar

More in this TOC Section

  • Parkinson disease primer, part 2: management of motor and nonmotor symptoms
  • Parkinson disease primer, part 1: diagnosis
  • Prescribing for common complications of spinal cord injury
Show more Clinical Review

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • RSS Feeds

Copyright © 2023 by The College of Family Physicians of Canada

Powered by HighWire